I agree that this site is using cookies. You can find further informations here.
X
Yasui, Atsutaka
35  results:
Search for persons X
?
1

Empagliflozin is associated with lower risk of cardiovascul..:

Kim, Dae Jung ; Sheu, Wayne H‐H ; Chung, Wook‐Jin...
Journal of Diabetes Investigation.  14 (2023)  3 - p. 417-428 , 2023
Link: https://doi.org/10.1111/..
 
?
2

The effect of empagliflozin on the total burden of cardiova..:

Kaku, Kohei ; Wanner, Christoph ; Anker, Stefan D....
Diabetes, Obesity and Metabolism.  24 (2022)  4 - p. 662-674 , 2022
Link: https://doi.org/10.1111/..
 
?
3

Safety and effectiveness of empagliflozin in Japanese patie..:

Kaku, Kohei ; Yamamoto, Kazuhiro ; Fukushima, Yumiko..
Expert Opinion on Drug Safety.  21 (2022)  10 - p. 1315-1328 , 2022
Link: https://doi.org/10.1080/..
 
?
4

Healthcare resource utilization in patients treated with em..:

Sheu, Wayne H‐H ; Seino, Yutaka ; Tan, Elise Chia‐Hui...
Journal of Diabetes Investigation.  13 (2022)  5 - p. 810-821 , 2022
Link: https://doi.org/10.1111/..
 
?
5

Rationale and design of the EMPA-ELDERLY trial: a randomise..:

Yabe, Daisuke ; Shiki, Kosuke ; Suzaki, Keiko...
BMJ Open.  11 (2021)  4 - p. e045844 , 2021
Link: https://doi.org/10.1136/..
 
?
6

Validity of Claims Diagnosis Codes for Cardiovascular Disea..:

Ono, Yasuhisa ; Taneda, Yusuke ; Takeshima, Tomomi..
Clinical Epidemiology.  12 (2020)  - p. 367-375 , 2020
Link: https://doi.org/10.2147/..
 
?
7

Cardiovascular and renal effectiveness of empagliflozin in ..:

Seino, Yutaka ; Kim, Dae Jung ; Yabe, Daisuke...
Endocrinology, Diabetes & Metabolism.  4 (2020)  1 - p. , 2020
Link: https://doi.org/10.1002/..
 
?
8

Safety and effectiveness of empagliflozin in Japanese patie..:

Kaku, Kohei ; Chin, Rina ; Naito, Yusuke...
Expert Opinion on Drug Safety.  19 (2019)  2 - p. 211-221 , 2019
Link: https://doi.org/10.1080/..
 
?
9

Cost-effectiveness Analysis of Empagliflozin in Japan Based..:

Kaku, Kohei ; Haneda, Masakazu ; Sakamaki, Hiroyuki...
Clinical Therapeutics.  41 (2019)  10 - p. 2021-2040.e11 , 2019
Link: https://doi.org/10.1016/..
 
?
10

Empagliflozin as adjunct to insulin in Japanese participant..:

Shimada, Akira ; Hanafusa, Toshiaki ; Yasui, Atsutaka...
Diabetes, Obesity and Metabolism.  20 (2018)  9 - p. 2190-2199 , 2018
Link: https://doi.org/10.1111/..
 
?
11

Safety and tolerability of empagliflozin in East Asian pati..:

Yabe, Daisuke ; Yasui, Atsutaka ; Ji, Linong...
Journal of Diabetes Investigation.  10 (2018)  2 - p. 418-428 , 2018
Link: https://doi.org/10.1111/..
 
?
12

Empagliflozin Induces Transient Diuresis Without Changing L..:

Yasui, Atsutaka ; Lee, Ganghyuck ; Hirase, Tetsuaki...
Diabetes Therapy.  9 (2018)  2 - p. 863-871 , 2018
Link: https://doi.org/10.1007/..
 
?
13

URB is abundantly expressed in adipose tissue and dysregula..:

Okada, Takuya ; Nishizawa, Hitoshi ; Kurata, Akifumi...
Biochemical and Biophysical Research Communications.  367 (2008)  2 - p. 370-376 , 2008
Link: https://doi.org/10.1016/..
 
?
14

Foxo1 represses expression of musclin, a skeletal muscle-de..:

Yasui, Atsutaka ; Nishizawa, Hitoshi ; Okuno, Yosuke...
Biochemical and Biophysical Research Communications.  364 (2007)  2 - p. 358-365 , 2007
Link: https://doi.org/10.1016/..
 
?
15

Sulfonylurea Agents Exhibit Peroxisome Proliferator-activat..:

Fukuen, Shuichi ; Iwaki, Masanori ; Yasui, Atsutaka...
Journal of Biological Chemistry.  280 (2005)  25 - p. 23653-23659 , 2005
Link: https://doi.org/10.1074/..
 
1-15